Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation

BackgroundHypoxia-induced radioresistance constitutes a major obstacle for a curative treatment of cancer. The aim of this study was to investigate effects of photon and carbon ion irradiation in combination with inhibitors of DNA-Damage Response (DDR) on tumor cell radiosensitivity under hypoxic conditions.MethodsHuman non-small cell lung cancer (NSCLC) models, A549 and H1437, were irradiated with dose series of photon and carbon ions under hypoxia (1% O2) vs. normoxic conditions (21% O2). Clonogenic survival was studied after dual combinations of radiotherapy with inhibitors of DNA-dependent Protein Kinase (DNAPKi, M3814) and ATM serine/threonine kinase (ATMi).ResultsThe OER at 30% survival for photon irradiation of A549 cells was 1.4. The maximal oxygen effect measured as survival ratio was 2.34 at 8 Gy photon irradiation of A549 cells. In contrast, no significant oxygen effect was found after carbon ion irradiation. Accordingly, the relative effect of 6 Gy carbon ions was determined as 3.8 under normoxia and. 4.11 under hypoxia. ATM and DNA-PK inhibitors dose dependently sensitized tumor cells for both radiation qualities. For 100 nM DNAPKi the survival ratio at 4 Gy more than doubled from 1.59 under normoxia to 3.3 under hypoxia revealing a strong radiosensitizing effect under hypoxic conditions. In contrast, this ratio only moderately increased after photon irradiation and ATMi under hypoxia. The most effective treatment was combined carbon ion irradiation and DNA damage repair inhibition.ConclusionsCarbon ions efficiently eradicate hypoxic tumor cells. Both, ATMi and DNAPKi elicit radiosensitizing effects. DNAPKi preferentially sensitizes hypoxic cells to radiotherapy.

[1]  W. Weichert,et al.  Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  M. Durante,et al.  Kill-painting of hypoxic tumours in charged particle therapy , 2015, Scientific Reports.

[3]  L. Damstrup,et al.  M3814, a DNA-dependent Protein Kinase Inhibitor (DNA-PKi), Potentiates the Effect of Ionizing Radiation (IR) in Xenotransplanted Tumors in Nude Mice , 2016 .

[4]  N. Curtin,et al.  DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin , 2013, Breast Cancer Research and Treatment.

[5]  P. Glazer,et al.  Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment. , 2015, DNA repair.

[6]  A. Brahme,et al.  Radiobiological description of the LET dependence of the cell survival of oxic and anoxic cells irradiated by carbon ions , 2012, Journal of radiation research.

[7]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.

[8]  Shuguang Huang,et al.  Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data , 2006, BMC Genomics.

[9]  Jan J Wilkens,et al.  Modelling of the oxygen enhancement ratio for ion beam radiation therapy , 2011, Physics in medicine and biology.

[10]  A. Minchinton,et al.  Selective radiosensitization of hypoxic cells using BCCA621C: a novel hypoxia activated prodrug targeting DNA-dependent protein kinase , 2013 .

[11]  M. Uesaka,et al.  Nontoxic concentration of DNA‐PK inhibitor NU7441 radio‐sensitizes lung tumor cells with little effect on double strand break repair , 2016, Cancer science.

[12]  J. Debus,et al.  Next generation multi-scale biophysical characterization of high precision cancer particle radiotherapy using clinical proton, helium-, carbon- and oxygen ion beams , 2016, Oncotarget.

[13]  H. Rodemann,et al.  Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation. , 2015, Seminars in cancer biology.

[14]  H. Rodemann,et al.  Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Fons Rademakers,et al.  ROOT — An object oriented data analysis framework , 1997 .

[16]  B. S. Sørensen,et al.  Relative biological effectiveness of carbon ions for tumor control, acute skin damage and late radiation-induced fibrosis in a mouse model , 2015, Acta oncologica.

[17]  M. Durante,et al.  Influence of acute hypoxia and radiation quality on cell survival , 2013, Journal of radiation research.

[18]  Johan Bussink,et al.  Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  F. Rademakers,et al.  ROOT — An object oriented data analysis framework , 1997 .

[20]  S. McKeown,et al.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. , 2014, The British journal of radiology.

[21]  Matthias Reimold,et al.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Donald Wlodkowic,et al.  Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy. , 2009, European journal of pharmacology.

[23]  N. Curtin,et al.  Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer , 2013, Molecular Cancer Therapeutics.

[24]  M Durante,et al.  Including oxygen enhancement ratio in ion beam treatment planning: model implementation and experimental verification , 2013, Physics in medicine and biology.

[25]  T. Fuchss,et al.  Abstract 1658: M3814, a novel investigational DNA-PK inhibitor: enhancing the effect of fractionated radiotherapy leading to complete regression of tumors in mice , 2016 .

[26]  T. Inaniwa,et al.  Adaptation of the microdosimetric kinetic model to hypoxia , 2016, Physics in medicine and biology.

[27]  O Jäkel,et al.  Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. , 2000, Physics in medicine and biology.

[28]  Katia Parodi,et al.  Phase Space Generation for Proton and Carbon Ion Beams for External Users’ Applications at the Heidelberg Ion Therapy Center , 2016, Front. Oncol..

[29]  B. Wouters,et al.  Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.

[30]  S. Curtis.  Calculated LET distributions of heavy ion beams. , 1977, International journal of radiation oncology, biology, physics.

[31]  Jens Overgaard,et al.  Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  M. Quintiliani.  The oxygen effect in radiation inactivation of DNA and enzymes. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[33]  J. Ward,et al.  DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. , 1988, Progress in nucleic acid research and molecular biology.

[34]  Maximilien Vermandel,et al.  Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study) , 2017, The Journal of Nuclear Medicine.